Dr. Bob Martin Show

What happens when half-priced Ozempic suddenly disappears faster than a donut at a dietconvention? The FDA just pulled the plug on compounded GLP-1 drugs, leaving millions scramblingto choose between $1,300/month prescriptions and back-alley “discounts” riskier than a gas stationsushi platter. Dive into the chaos: patients like Michelle facing spine surgery relapses, Big Pharma’slegal smackdowns, and why docs compare off-brand meds to “pancreas malware.” But don’t panicyet—we’ve got your survival playbook, plus a wildcard solution involving beer’s bitter cousin. Stickaround to discover how Calocurb—a hop-based supplement—might outsmart hunger hormoneswithout needles or shady pharmacies. Your next craving killer could grow in a field, not a lab.Special Guest: Sarah Kennedy – CEO of Calocurb, a natural GLP-1 activator